229 related articles for article (PubMed ID: 38051146)
41. Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis.
Nicolas SE; Bear MD; Kanaan AO; Coman OA; Dima L
Am J Ther; 2023 Nov-Dec 01; 30(6):e535-e542. PubMed ID: 37921681
[TBL] [Abstract][Full Text] [Related]
42. Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.
Lebwohl MG; Sugarman JL; Stein Gold L; Lin T; Israel R
J Drugs Dermatol; 2019 Oct; 18(10):1012-1018. PubMed ID: 31584780
[TBL] [Abstract][Full Text] [Related]
43. The opposite effect of tapinarof between IMQ and IL-23 induced psoriasis mouse models.
Zhu X; Han R; Tian X; Hochgerner M; Li H; Wang J; Xia J
Exp Dermatol; 2024 Jan; 33(1):e14862. PubMed ID: 37350230
[TBL] [Abstract][Full Text] [Related]
44. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
45. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
46. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis.
Pinter A; Green LJ; Selmer J; Praestegaard M; Gold LS; Augustin M;
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):228-236. PubMed ID: 34628687
[TBL] [Abstract][Full Text] [Related]
47. Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial.
Sezer Z; Inal A; Cinar SL; Mazicioglu MM; Altug S; Karasulu HY; Diril M; Mehmetoglu Al A; Kozlu S; Ulu N
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1489-1501. PubMed ID: 37300792
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
[TBL] [Abstract][Full Text] [Related]
49. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial.
Kumar R; Dogra S; Amarji B; Singh B; Kumar S; Sharma ; Vinay K; Mahajan R; Katare OP
JAMA Dermatol; 2016 Jul; 152(7):807-15. PubMed ID: 27096709
[TBL] [Abstract][Full Text] [Related]
51. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
[TBL] [Abstract][Full Text] [Related]
52. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
53. Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
He C; Jin H; Liu X; Hu F; Zhang L; Zhang S; He Y; Yang X; Chen H; Wang X; Ji C; Lv C; Miao G; Li X; Diao Q; Li L; Li X; Li Y; Wang R; Zhang L; Zhou X; Xia X; Yan M; Song J; Zhang R; Geng L; Zheng M; Lu Q; Lu T; Shi Y; Jing H; Zhang X; Shi J; Xia J; Gao Y; Wang Y
Dermatology; 2021; 237(4):603-610. PubMed ID: 33352561
[TBL] [Abstract][Full Text] [Related]
54. New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 3: Roflumilast.
DiRuggiero M; Mancuso-Stewart E; DiRuggiero D; Zirwas M
Skinmed; 2023; 21(4):264-268. PubMed ID: 37771017
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of the topical cyclosporine cream assisted by fractional carbon dioxide laser vs topical clobetasol cream for the treatment of plaque psoriasis: Randomized comparative study.
Helmy A Y; El Batreek MH; Abdel Fadeel DA; Tawfik AA; Samy NA
J Cosmet Dermatol; 2022 Aug; 21(8):3362-3370. PubMed ID: 34791789
[TBL] [Abstract][Full Text] [Related]
56. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
57. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R
J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807
[No Abstract] [Full Text] [Related]
58. Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities.
Bhatia ND; Vlahovic TC; Green LG; Martin G; Lin T
J Drugs Dermatol; 2019 Oct; 18(10):1029-1036. PubMed ID: 31584782
[TBL] [Abstract][Full Text] [Related]
59. Noncorticosteroid Topical Therapies for the Treatment of Plaque Psoriasis: A Narrative Review.
Chandy RJ; Dao DD; Rivis CC; Shan DM; Feldman SR
J Pharm Technol; 2023 Oct; 39(5):247-255. PubMed ID: 37745732
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
